Global Botanical and Plant Derived Drugs Market Trends, Applications, Analysis, Growth, and Forecast to 2027
MarketResearch.biz delivers in-depth insights on the global botanical and plant derived drugs market in its upcoming report titled, “Global Botanical and Plant Derived Drugs Market Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global botanical and plant derived drugs market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018 to 2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global botanical and plant derived drugs market has been segmented on the basis of source, dosage form, therapeutic application, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Drugs which are derived from medicinal plants are known as botanical drugs. Medicinal plants could contain algae, vegetable materials, and microscopic fungi. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi-synthetic substances. These drugs are used in treatment of various diseases such as central nervous system disorders, cardiovascular diseases, infectious diseases, and respiratory diseases. These drugs are used as an important component of traditional medicine and therapies such as homeopathy and ayurvedic medicines. Botanical derived drugs are available in various forms such as pills, tablets, and injections.
Increasing adoption of plant-based drugs across developed and developing economies is a major factor driving growth of the global botanical and plant derived drugs market. In addition, low cost of botanical and plant derived drugs as compared to specialty drugs is another factor expected to propel growth of the target market over the forecast period. Furthermore, technological advancements in manufacturing equipment for botanical drugs is a factor expected to drive growth of the target market in the near future. Also, emerging large herbal drug manufacturing companies across the globe is a factor expected to fuel growth of the global botanical and plant derived drugs market over the forecast period.
However, stringent government regulations associated with approval of botanical drugs is a factor expected to limit growth of the global botanical and plant derived drugs market over the forecast period.
Currently, markets in North America and Europe accounts for significant market share in the global botanical and plant derived drugs market in terms of revenue. This can be attributed to growing awareness towards botanical and plant derived drugs coupled with increasing prevalence of chronic diseases in the region. In addition, technological advancement in production procedure of botanical is also supporting growth of botanical and plant derived drugs in these regions. The market in Asia Pacific is expected to witness moderate growth over the forecast period, owing to increasing population coupled with rising awareness towards plant derived drugs in the region. Also the market in North America is expected to register a CAGR of X.X% during the forecast period.
Global botanical and plant derived drugs market segmentation:
- Macroscopic fungi
By dosage form:
By therapeutic application:
- Central Nervous System
- Cardiovascular Diseases
- Infectious Diseases
- Respiratory Diseases
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Bayer Healthcare LLC
- GlaxoSmithKline plc
- Pfizer, Inc.
- Actelion Pharmaceuticals Ltd
- Aimil Pharmaceuticals India Ltd
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Concordia Pharmaceuticals Inc.
- GW Pharmaceuticals plc
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!